Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research
Authors:
- Maria Isabel Alvarez-MoraMAMaria Isabel Alvarez-Mora
- Glòria GarrabouGGGlòria Garrabou
- Laura Molina-PorcelLMLaura Molina-Porcel
- Ruben Grillo-RiscoRGRuben Grillo-Risco
- Francisco Garcia-GarciaFGFrancisco Garcia-Garcia
- Tamara BarcosTBTamara Barcos
- Judith Cantó-SantosJCJudith Cantó-Santos
- Laia Rodriguez-RevengaLRLaia Rodriguez-Revenga
Open Access
Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that appears in adult FMR1 premutation carriers. The neuropathological hallmark of FXTAS is an intranuclear inclusion in neurons and astrocytes. Nearly 200 different proteins have been identified in FXTAS inclusions, being the small ubiquitin-related modifier 2 (SUMO2), ubiquitin and p62 the most highly abundant. These proteins are components of the protein degradation machinery. This study aimed to characterize SUMO2/3 expression levels and autophagy process in human postmortem brain samples and skin fibroblast cultures from FXTAS patients. Results revealed that FXTAS postmortem brain samples are positive for SUMO2/3 conjugates and supported the idea that SUMO2/3 accumulation is involved in inclusion formation. Insights from RNA-sequencing data indicated that SUMOylation processes are significantly upregulated in FXTAS samples. In addition, the analysis of the autophagy flux showed the accumulation of p62 protein levels and autophagosomes in skin fibroblasts from FXTAS patients. Similarly, gene set analysis evidenced a significant downregulation in gene ontology terms related to autophagy in FXTAS samples. Overall, this study provides new evidence supporting the role of SUMOylation and autophagic processes in the pathogenic mechanisms underlying FXTAS.Keywords
Funding Information
- Instituto de Salud Carlos III (ISCIII) (PI17/01067, PI18/0049, PI21/00935, PI21/01085, PI20/0448, 2021-SGR-01492)
- Autonomous Catalan Government (PI17/01067, PI18/0049, PI21/00935, PI21/01085, PI20/0448, 2021-SGR-01492)
This publication has 38 references indexed in Scilit:
- Proteostasis of polyglutamine varies among neurons and predicts neurodegenerationNature Chemical Biology, 2013
- Activation of mTOR Ameliorates Fragile X Premutation rCGG Repeat-Mediated NeurodegenerationPLOS ONE, 2013
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Cellular Strategies of Protein Quality ControlCold Spring Harbor Perspectives in Biology, 2011
- Comparative Proteomic Analysis Identifies a Role for SUMO in Protein Quality ControlScience Signaling, 2011
- Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndromeHuman Molecular Genetics, 2011
- Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndromeBiochemical Journal, 2010
- Multidimensional Gene Set Analysis of Genomic DataPLOS ONE, 2010
- Penetrance of FMR1 premutation associated pathologies in fragile X syndrome familiesEuropean Journal of Human Genetics, 2009
- The Ubiquitin-Proteasome System Is a Key Component of the SUMO-2/3 CycleMolecular & Cellular Proteomics, 2008